# OnCo record olema-pharmaceuticals (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/olema-pharmaceuticals/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "olema-pharmaceuticals" ;
  schema:name "Olema Pharmaceuticals"@en ;
  schema:alternateName "Olema Pharmaceuticals, Inc."@en ;
  schema:description "Olema Pharmaceuticals is a United States-based biotechnology company running 2 late-stage cancer trials in HR-positive / HER2-negative breast cancer."@en ;
  schema:url <https://onco.cc/companies/olema-pharmaceuticals/>, <https://www.olema.com> ;
  schema:dateModified "2026-09-11"^^xsd:date ;
  schema:citation <https://www.olema.com>, <https://clinicaltrials.gov/search?lead=Olema%20Pharmaceuticals%2C%20Inc.>, <https://www.olema.com/pipeline> ;
  onco:tag "ctgov-sponsor" ;
  schema:addressCountry "US" ;
  onco:cancers <https://onco.cc/cancers/breast-hr-positive/> ;
  onco:drugs <https://onco.cc/drugs/ribociclib/> ;
  onco:trials <https://onco.cc/trials/nct06016738/>, <https://onco.cc/trials/nct07085767/> .